Inform Genomics
Boston · Founded 2010
About Inform Genomics
Inform Genomics is a private company focused on developing a novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. Their business model leverages existing technology in conjunction with proprietary analytic methods for conducting genome-wide association studies. Product development programs will lead to commercial, single source laboratory tests consisting of SNP clusters that determine the likelihood of individual patient clinical outcomes to drug therapies. The U.S. market opportunity for these differentiated products exceeds $2 billion annually. Inform Genomics is headquartered in Boston, Massachusetts.
Company Facts
- Founded: 2010
- Legal name: Inform Genomics, Inc.
- Operating status: Closed
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Last round: Series Unknown (Feb 2014)
- Website: informgenomics.net
Canonical: https://fsome.com/organization/inform-genomics-8250505 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.